AAAAAA
Results: 1-25/70
Authors:
Blake, GJ
Dada, N
Fox, JC
Manson, JE
Ridker, PM
Citation: Gj. Blake et al., A prospective evaluation of lipoprotein-associated phospholipase A(2) levels and the risk of future cardiovascular events in women, J AM COL C, 38(5), 2001, pp. 1302-1306
Authors:
Christen, WG
Howell, TH
Ridker, PM
Citation: Wg. Christen et al., Periodontal disease and risk of myocardial infarction - Reply, J AM COL C, 38(4), 2001, pp. 1273-1274
Authors:
Howell, TH
Ridker, PM
Ajani, UA
Hennekens, CH
Christen, WG
Citation: Th. Howell et al., Periodontal disease and risk of subsequent cardiovascular disease in US male physicians, J AM COL C, 37(2), 2001, pp. 445-450
Authors:
Miles, JS
Miletich, JP
Goldhaber, SZ
Hennekens, CH
Ridker, PM
Citation: Js. Miles et al., G20210A mutation in the prothrombin gene and the risk of recurrent venous thromboembolism, J AM COL C, 37(1), 2001, pp. 215-218
Authors:
Zee, RYL
Lunze, K
Lindpaintner, K
Ridker, PM
Citation: Ryl. Zee et al., A prospective evaluation of the interleukin-1 receptor antagonist intron 2gene polymorphism and the risk of myocardial infarction, THROMB HAEM, 86(5), 2001, pp. 1141-1143
High sensitivity C-reactive protein for predicting cardiovascular disease:an inflammatory hypothesis
Authors:
Blake, GJ
Ridker, PM
Citation: Gj. Blake et Pm. Ridker, High sensitivity C-reactive protein for predicting cardiovascular disease:an inflammatory hypothesis, EUR HEART J, 22(5), 2001, pp. 349-352
Authors:
Ridker, PM
Citation: Pm. Ridker, Should statin therapy be considered for patients with elevated C-reactive protein? The need for a definitive clinical trial, EUR HEART J, 22(23), 2001, pp. 2135-2137
Authors:
Chae, CU
Lee, RT
Rifai, N
Ridker, PM
Citation: Cu. Chae et al., Blood pressure and inflammation in apparently healthy men, HYPERTENSIO, 38(3), 2001, pp. 399-403
Authors:
Ridker, PM
Citation: Pm. Ridker, Role of inflammatory biomarkers in prediction of coronary heart disease, LANCET, 358(9286), 2001, pp. 946-948
Authors:
Pradhan, AD
Manson, JE
Rifai, N
Buring, JE
Ridker, PM
Citation: Ad. Pradhan et al., C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus, J AM MED A, 286(3), 2001, pp. 327-334
Authors:
Albert, MA
Danielson, E
Rifai, N
Ridker, PM
Citation: Ma. Albert et al., Effect of statin therapy on C-reactive protein levels - The Pravastatin Inflammation/CRP Evaluation (PRINCE): A randomized trial and cohort study, J AM MED A, 286(1), 2001, pp. 64-70
Authors:
Ridker, PM
Stampfer, MJ
Rifai, N
Citation: Pm. Ridker et al., Novel risk factors for systemic atherosclerosis - A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease, J AM MED A, 285(19), 2001, pp. 2481-2485
Authors:
Ridker, PM
Gotto, AM
Citation: Pm. Ridker et Am. Gotto, The antiinflammatory effects of statins. Reply, N ENG J MED, 345(16), 2001, pp. 1210-1211
Authors:
Hines, LM
Stampfer, MJ
Ma, J
Gaziano, JM
Ridker, PM
Hankinson, SE
Sacks, F
Rimm, EB
Hunter, DJ
Citation: Lm. Hines et al., Genetic variation in alcohol dehydrogenase and the beneficial effect of moderate alcohol consumption on myocardial infarction., N ENG J MED, 344(8), 2001, pp. 549-555
Authors:
Ridker, PM
Rifai, N
Clearfield, M
Downs, JR
Weis, SE
Miles, JS
Gotto, AM
Citation: Pm. Ridker et al., Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events, N ENG J MED, 344(26), 2001, pp. 1959-1965
Authors:
Herrington, DM
Brosnihan, KB
Pusser, BE
Seely, EW
Ridker, PM
Rifai, N
MacLean, DB
Citation: Dm. Herrington et al., Differential effects of E and droloxifene on C-reactive protein and other markers of inflammation in healthy postmenopausal women, J CLIN END, 86(9), 2001, pp. 4216-4222
Authors:
Zee, RYL
Lindpaintner, K
Struk, B
Hennekens, CH
Ridker, PM
Citation: Ryl. Zee et al., A prospective evaluation of the CD14 C(-260)T gene polymorphism and the risk of myocardial infarction, ATHEROSCLER, 154(3), 2001, pp. 699-702
Authors:
Rifai, N
Ridker, PM
Citation: N. Rifai et Pm. Ridker, High-sensitivity C-reactive protein: A novel and promising marker of coronary heart disease, CLIN CHEM, 47(3), 2001, pp. 403-411
Authors:
Meier-Ewert, HK
Ridker, PM
Rifai, N
Price, N
Dinges, DF
Mullington, JM
Citation: Hk. Meier-ewert et al., Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects, CLIN CHEM, 47(3), 2001, pp. 426-430
Authors:
Ockene, IS
Matthews, CE
Rifai, N
Ridker, PM
Reed, G
Stanek, E
Citation: Is. Ockene et al., Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults, CLIN CHEM, 47(3), 2001, pp. 444-450
Authors:
Rifai, N
Ridker, PM
Citation: N. Rifai et Pm. Ridker, Proposed cardiovascular risk assessment algorithm using high-sensitivity C-reactive protein and lipid screening, CLIN CHEM, 47(1), 2001, pp. 28-30
Authors:
Blake, GJ
Ridker, PM
Citation: Gj. Blake et Pm. Ridker, Novel clinical markers of vascular wall inflammation, CIRCUL RES, 89(9), 2001, pp. 763-771
Authors:
Schonbeck, U
Varo, N
Libby, P
Buring, J
Ridker, PM
Citation: U. Schonbeck et al., Soluble CD40L and cardiovascular risk in women, CIRCULATION, 104(19), 2001, pp. 2266-2268
Authors:
Ridker, PM
Rifai, N
Lowenthal, SP
Citation: Pm. Ridker et al., Rapid reduction in C-reactive protein with cerivastatin among 785 patientswith primary hypercholesterolemia, CIRCULATION, 103(9), 2001, pp. 1191-1193
Authors:
Ridker, PM
Buring, JE
Rifai, N
Citation: Pm. Ridker et al., Soluble P-selectin and the risk of future cardiovascular events, CIRCULATION, 103(4), 2001, pp. 491-495